CN Stock MarketDetailed Quotes
603168 Zhejiang Shapuaisi Pharmaceutical
- 6.21
- -0.19-2.97%
Market Closed Sep 6 15:00 CST
2.35BMarket Cap-32343P/E (TTM)
6.44High6.20Low33.29KlotVolume6.37Open6.40Pre Close20.93MTurnover1.03%Turnover Ratio92.69P/E (Static)379.16MShares15.7852wk High1.39P/B2.00BFloat Cap6.0352wk Low7.04Limit Up322.59MShs Float55.88Historical High5.76Limit Down3.75%Amplitude4.94Historical Low0.02Dividend TTM6.29Avg Price22.42KlotAsk0.34%Div YieldTTM100Lot Size10.14KlotBid
Zhejiang Shapuaisi Pharmaceutical Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -11.98%248.48M | 5.15%145.03M | 13.43%628.06M | 10.51%420.47M | 5.49%282.3M | -18.74%137.93M | -18.07%553.68M | -23.04%380.48M | -24.63%267.61M | 5.82%169.74M |
| Refunds of taxes and levies | ---- | ---- | ---- | ---- | ---- | ---- | 950.16%12.94M | ---- | ---- | ---- |
| Cash received relating to other operating activities | -61.45%13.15M | 20.94%6.11M | 42.32%8.68M | 70.56%39.93M | 121.94%34.1M | -31.32%5.05M | -19.90%6.1M | -18.59%23.41M | 110.07%15.37M | 190.79%7.36M |
| Cash inflows from operating activities | -17.31%261.63M | 5.71%151.15M | 11.18%636.74M | 13.99%460.4M | 11.81%316.4M | -19.26%142.98M | -16.35%572.73M | -23.19%403.89M | -21.91%282.97M | 8.69%177.1M |
| Goods services cash paid | -23.99%59.9M | -6.06%33.01M | 79.67%193.67M | 72.04%109.24M | 82.73%78.81M | 41.76%35.14M | -10.38%107.79M | -26.96%63.49M | -35.56%43.13M | -7.93%24.79M |
| Staff behalf paid | 15.37%89.62M | 28.04%49.35M | 7.19%155.54M | 9.98%113.02M | 5.08%77.69M | -9.91%38.54M | 2.08%145.1M | 3.84%102.76M | 23.54%73.93M | 15.88%42.78M |
| All taxes paid | -43.61%19.26M | -39.21%11.76M | -28.84%44.51M | -30.09%41.87M | -26.86%34.15M | -20.08%19.35M | -10.86%62.55M | -8.55%59.89M | -4.47%46.69M | -13.72%24.21M |
| Cash paid relating to other operating activities | -14.70%102.97M | -9.17%51.75M | 42.36%201.53M | 46.61%201.51M | 39.45%120.72M | 4.07%56.97M | -43.67%141.57M | -40.79%137.45M | -9.52%86.57M | -6.49%54.75M |
| Cash outflows from operating activities | -12.72%271.76M | -2.76%145.87M | 30.25%595.25M | 28.07%465.64M | 24.39%311.36M | 2.37%150.01M | -21.73%457M | -24.80%363.6M | -7.74%250.32M | -2.61%146.53M |
| Net cash flows from operating activities | -300.86%-10.13M | 175.05%5.27M | -64.14%41.49M | -113.02%-5.24M | -84.56%5.04M | -122.98%-7.02M | 14.82%115.72M | -4.83%40.3M | -64.14%32.66M | 144.92%30.57M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | --10M | -23.24%67.6M | --54.18M | --41.18M | ---- | 110.58%88.06M | ---- | ---- | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 143.59%38K | --8K | -76.01%84.1K | -95.10%15.6K | -95.10%15.6K | ---- | -27.86%350.6K | -34.44%318.6K | -30.74%318.6K | --3K |
| Cash received relating to other investing activities | -74.01%10.09M | -99.60%92K | 1.72%148.33M | -81.93%42.26M | -79.90%38.83M | -88.07%23.04M | -58.74%145.83M | -33.75%233.89M | -23.65%193.17M | 91.37%193.17M |
| Cash inflows from investing activities | -87.34%10.13M | -56.17%10.1M | -7.78%216.02M | -58.82%96.45M | -58.64%80.02M | -88.07%23.04M | -40.81%234.24M | -40.76%234.21M | -23.66%193.49M | 91.37%193.18M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 23.80%101.21M | 206.87%42.72M | 47.82%219.8M | 57.52%160.77M | 42.27%81.75M | -58.51%13.92M | -3.10%148.69M | 10.91%102.06M | 868.87%57.46M | 4,097.27%33.55M |
| Cash paid to acquire investments | 1.73%159.62M | 121.22%159.62M | 132.07%162.45M | 137.00%165.9M | 124.14%156.9M | 44.31%72.15M | --70M | --70M | --70M | --50M |
| Net cash paid to acquire subsidiaries and other business units | --6.65M | ---- | --51.66M | ---- | ---- | --11.76M | ---- | ---- | ---- | ---- |
| Cash paid relating to other investing activities | ---- | ---- | 113.33%128M | -73.39%16M | -60.13%16M | -85.09%3M | -40.00%60M | -39.87%60.13M | -19.75%40.13M | --20.13M |
| Cash outflows from investing activities | 5.04%267.48M | 100.66%202.34M | 101.63%561.91M | 47.58%342.67M | 51.95%254.65M | -2.74%100.84M | 9.96%278.69M | -40.89%232.19M | -34.72%167.59M | 12,870.44%103.68M |
| Net cash flows from investing activities | -47.37%-257.35M | -147.11%-192.24M | -678.23%-345.89M | -12,285.98%-246.22M | -774.24%-174.63M | -186.92%-77.79M | -131.24%-44.45M | -20.74%2.02M | 893.96%25.9M | -10.63%89.5M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | -91.40%27.92M | --27.92M | ---- | ---- | --324.6M | ---- | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | --10M | ---- | ---- | ---- |
| Cash from borrowing | 91.37%130M | --30M | 220.27%153.73M | 178.81%133.83M | 41.52%67.93M | ---- | --48M | --48M | --48M | ---- |
| Cash inflows from financing activities | 91.37%130M | --30M | -51.25%181.65M | 236.98%161.75M | 41.52%67.93M | ---- | --372.6M | --48M | --48M | ---- |
| Borrowing repayment | --50.3M | --100K | -57.50%20.4M | ---- | ---- | ---- | --48M | --48M | --48M | ---- |
| Dividend interest payment | -22.76%10.96M | --1.32M | --16.25M | --15.02M | --14.2M | ---- | ---- | ---- | ---- | ---- |
| Cash payments relating to other financing activities | --5.76M | ---- | 7.00%9.99M | ---- | ---- | ---- | -95.58%9.34M | ---- | ---- | ---- |
| Cash outflows from financing activities | 372.14%67.03M | --1.42M | -18.65%46.64M | -68.71%15.02M | -70.42%14.2M | ---- | -72.87%57.34M | --48M | --48M | ---- |
| Net cash flows from financing activities | 17.20%62.97M | --28.58M | -57.18%135.01M | --146.73M | --53.73M | ---- | 249.18%315.26M | ---- | ---- | ---- |
| Net cash flow | ||||||||||
| Net increase in cash and cash equivalents | -76.51%-204.5M | -86.74%-158.39M | -143.82%-169.39M | -347.50%-104.73M | -297.85%-115.86M | -170.64%-84.82M | 1,117.69%386.54M | -5.73%42.32M | -33.32%58.56M | 6.61%120.06M |
| Add:Begin period cash and cash equivalents | -32.26%355.67M | -32.26%355.67M | 279.04%525.06M | 279.04%525.06M | 279.04%525.06M | 279.04%525.06M | 29.73%138.52M | 29.73%138.52M | 29.73%138.52M | 29.73%138.52M |
| End period cash equivalent | -63.06%151.17M | -55.19%197.28M | -32.26%355.67M | 132.43%420.32M | 107.63%409.2M | 70.25%440.24M | 279.04%525.06M | 19.23%180.84M | 1.28%197.08M | 17.86%258.59M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- |
| Auditor | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg